Overview
Obligated since award on contracts active FY2021–FY2026
Click a company to open its profile.
Insight 260-NETWORK CONTRACT OFFICE 20 (36C260) is its largest buyer. See more on the Buyers tab
Agencies report with a delay; the latest year will rise
Hover over a year to see its value.
Insight Largest year: $238K in FY2023. See more on the Contracts tab
Click a state to open its page.
- Florida$317K · 52%
- Tennessee$174K · 29%
- Virginia$86.7K · 14%
- Connecticut$29.9K · 4.9%
Insight 52% was performed in Florida. See more on the Contracts tab
Contracts
15 contracts with an action since FY2021
Click a tile to open its contract.
Insight 36F79719D0160 orders hold 86% of these contracts' obligations.
Click a bar to open its industry page.
Insight 86% under NAICS 325412.
Hover over a year to see its value.
Insight 85% of its prime obligations came through 36F79719D0160 orders.
Current end date of each prime contract with an action since FY2021
Hover over a month to see its value.
Catalyst Pharmaceuticals, Inc. prime contracts with an action in FY2021–FY2026
Find a contract by vehicle, office or end date; sort by money to see the largest.
0 end within 12 months.
Showing 1–10 of 15 contracts
| Since award, US$ | |||||
|---|---|---|---|---|---|
| Parent contract (IDVIDV: the record type for any contract that exists to take orders: IDIQs, GWACs, GSA Schedules, BPAs and basic ordering agreements. Glossary) | ObligatedObligation: money the government has legally committed to a contract. It is not the same as money paid. Example: $6M obligated of a $10M ceiling. Glossary | ||||
| 36C26022F0038 | 36F79719D0160 | 260-NETWORK CONTRACT OFFICE 20 (36C260) | $154,860 | Oct 31, 2022 | Ended |
| 36C26023F0042 | 36F79719D0160 | 260-NETWORK CONTRACT OFFICE 20 (36C260) | $132,866 | Oct 31, 2023 | Ended |
| HDTRA121P0012 | Stand-alone | DEFENSE THREAT REDUCTION AGENCY (HDTRA1) | $86,650 | Apr 30, 2022 | Ended |
| 36C24523N0425 | 36F79719D0160 | 245-NETWORK CONTRACT OFFICE 5 (36C245) | $34,394 | Mar 23, 2023 | Ended |
| 36C24121F0084 | 36F79719D0160 | 241-NETWORK CONTRACT OFFICE 01 (36C241) | $29,917 | Apr 30, 2021 | Ended |
| 36C26022F0022 | 36F79719D0160 | 260-NETWORK CONTRACT OFFICE 20 (36C260) | $29,692 | Dec 19, 2021 | Ended |
| 36C24526N0322 | 36F79719D0160 | 245-NETWORK CONTRACT OFFICE 5 (36C245) | $19,549 | Feb 16, 2026 | Ended |
| 36C24526N0193 | 36F79719D0160 | 245-NETWORK CONTRACT OFFICE 5 (36C245) | $18,978 | Dec 19, 2025 | Ended |
| 36C24525N1037 | 36F79719D0160 | 245-NETWORK CONTRACT OFFICE 5 (36C245) | $18,978 | Sep 29, 2025 | Ended |
| 36C24524N0953 | 36F79719D0160 | 245-NETWORK CONTRACT OFFICE 5 (36C245) | $18,526 | Sep 27, 2024 | Ended |
Buyers
Department of Veterans Affairs: $522K obligated since award; $483K in FY2021–FY2025 actions
Click a tile to open its office page.
Insight Department of Veterans Affairs placed 86%.
Contracting offices that awarded Catalyst Pharmaceuticals prime contracts, FY2021–FY2026
See which offices award its contracts.
2 offices awarded only one contract.
Showing 1–4 of 4 offices
| Contracts active FY2021–FY2026; obligated since award, US$ | |||||
|---|---|---|---|---|---|
| 260-NETWORK CONTRACT OFFICE 20 (36C260) | Department of Veterans Affairs | 4 | $317,417 | Oct 1, 2021 | Aug 19, 2024 |
| 245-NETWORK CONTRACT OFFICE 5 (36C245) | Department of Veterans Affairs | 9 | $174,293 | Jul 9, 2022 | Feb 12, 2026 |
| DEFENSE THREAT REDUCTION AGENCY (HDTRA1) | Defense Threat Reduction Agency | 1 | $86,650 | Mar 22, 2021 | Feb 28, 2022 |
| 241-NETWORK CONTRACT OFFICE 01 (36C241) | Department of Veterans Affairs | 1 | $29,917 | Dec 2, 2020 | Nov 17, 2021 |
Opportunities
Open opportunities matching Catalyst Pharmaceuticals, Inc.'s registered industries
Notices in its 1 industry (NAICSNAICS code: a six-digit code for the kind of work a company does. Each contract carries one, and it sets the small-business size limit. Glossary): 325412
8 of the next 10 are due within 30 days.
Showing 1–10 of 10 opportunities
| Opportunity | Agency | Due |
|---|---|---|
| 6505--Sodium Bicarbonate Injection Vial Restricted to Made in America (opens in Procura)Presolicitation · NAICS 325412Free account: full notice, dates, attachments | Department of Veterans AffairsNAC PHARMACEUTICALS (36E797) | Oct 21, 2026 |
| Inhaled Nitric Oxide (opens in Procura)Sources Sought · NAICS 325412Free account: full notice, dates, attachments | Defense Health Agency (DOD)DEFENSE HEALTH AGENCY (HT9408) | Oct 22, 2026 |
| Methylphenidate ER (opens in Procura)Solicitation · NAICS 325412Free account: full notice, dates, attachments | Defense Logistics Agency (DOD)DLA TROOP SUPPORT (SPE2D2) | Oct 23, 2026 |
| Department of War Pharmacy Uniform Formulary Blanket Purchase Agreement / Uniform Formulary Additional Discount Program (opens in Procura)Solicitation · NAICS 325412Free account: full notice, dates, attachments | Defense Health Agency (DOD)DEFENSE HEALTH AGENCY (DHA) (HT0040) | Oct 26, 2026 |
| 6505--Imatinib Tablets (opens in Procura)Solicitation · NAICS 325412Free account: full notice, dates, attachments | Department of Veterans AffairsNAC PHARMACEUTICALS (36E797) | Oct 30, 2026 |
| 6505--FY27 Low Energy General Radiopharmaceuticals 36C25027Q0052 (opens in Procura)Sources Sought · NAICS 325412Free account: full notice, dates, attachments | Department of Veterans Affairs250-NETWORK CONTRACT OFFICE 10 (36C250) | Nov 3, 2026 |
| LIDOCAINE 5% PATCHES-REQUEST FOR INFORMATION (opens in Procura)Sources Sought · NAICS 325412Free account: full notice, dates, attachments | Department of Veterans AffairsNATIONAL CMOP OFFICE (36C770) | Nov 3, 2026 |
| Epinephrine Injector (opens in Procura)Solicitation · NAICS 325412Free account: full notice, dates, attachments | Defense Logistics Agency (DOD)DLA TROOP SUPPORT (SPE2D2) | Nov 16, 2026 |
| 6505--Department of Veterans Affairs Pharmaceutical Industry Day (opens in Procura)Special Notice · NAICS 325412Free account: full notice, dates, attachments | Department of Veterans AffairsNAC FEDERAL SUPPLY SCHEDULE (36F797) | Nov 20, 2026 |
| TECHNOLOGY LICENSING OPPORTUNITY: Clathrate Therapeutics Platform (opens in Procura)Special Notice · NAICS 325412Free account: full notice, dates, attachments | Department of EnergyOffice 899015 | Dec 4, 2026 |
Registration and contacts
Registration
- UEI
- J1B2ARLKWN53
- CAGE code
- 5UTL7
- Registration
- Active, expires Mar 18, 2027
- Entity type
- Corporate Entity (Not Tax Exempt)
- Location
- CORAL GABLES, FL, 33134
- Congressional district
- FL-27
Registered industries (NAICSNAICS code: a six-digit code for the kind of work a company does. Each contract carries one, and it sets the small-business size limit. Glossary)
Registered in 1 industry; primary 325412
- 325412 Pharmaceutical Preparation ManufacturingPrimary
Contacts at Catalyst Pharmaceuticals, Inc.
| Contact | Role | As of |
|---|---|---|
| See contactsLocked · 7-day trial or paid plan (name, title and contact details with a 7-day trial or paid plan) | Government business POC · Company contactSAM.gov registrationSBA profileAs of Oct 19, 2026 | Oct 19, 2026 |
| See contactsLocked · 7-day trial or paid plan (name, title and contact details with a 7-day trial or paid plan) | Electronic business POCSAM.gov registrationAs of Oct 19, 2026 | Oct 19, 2026 |
| See contactsLocked · 7-day trial or paid plan (name, title and contact details with a 7-day trial or paid plan) | Alternate government business POCSAM.gov registrationAs of Oct 19, 2026 | Oct 19, 2026 |
Correct this listing
Tell us what to correct or add on the Catalyst Pharmaceuticals, Inc. page. We check every request before we change a profile.